Application of the Milan System for Reporting Salivary Gland Cytopathology: A 10-Year Experience in a Single Japanese Institution
Acta Cytologica · 2021 · 65 (2) · 123-131
DOI: 10.1159/000510990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cytologica, online erschienen am 28.10.2020. Verfasst von Yukiya Hirata und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of the Ryukyus Hospital, Okinawa, Japan, wind-ensemble@hotmail.co.jp. Hauptthemen laut MEDLINE: Terminology as Topic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is a recently published evidence-based categorization system for salivary gland fine-needle aspiration (FNA). We applied MSRSGC to Japanese cases and evaluated its utility. Study Design: A total of 480 FNA cases were reviewed. We recategorized each case into one of the MSRSGC categories. The risk of neoplasm (RON) and the risk of malignancy (ROM) for each diagnostic category in MSRSGC, and the sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) for malignancy and for neoplasms were calculated for cases with histological follow-up. In addition, the overall ROM (O-ROM) was calculated for all FNA cases.
Results
RON, ROM, and O-ROM rates were as follows – non-diagnostic: 51.3, 5.1, and 1.0%; non-neoplastic: 0, 0, and 0%; atypia of undetermined significance: 83.9, 12.9, and 7.3%; neoplasm, benign: 100, 0, and 0%; salivary gland neoplasm of uncertain malignant potential: 100, 32.1, and 23.7%; suspicious for malignancy: 100, 85.7, and 60%; and malignant: 100, 100, 81.8%. The sensitivity, specificity, and accuracy with (without) indeterminate cases for malignancy were 65 (100), 99 (99), 92% (99%) and PPV and NPV were 96 and 100%, respectively, and those for neoplasms were 84 (100), 100 (100), 85% (100%), and PPV and NPV were 100 and 100%, respectively.
Conclusions
The MSRSGC is useful for stratification of ROM and for promoting the performance of salivary gland FNA. The MSRSGC could be easily introduced in Japan and may improve the Japanese salivary gland FNA status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of the Ryukyus Hospital, Okinawa, Japan, wind-ensemble@hotmail.co.jp.
- Department of Surgical Pathology, Okinawa Kyodo Hospital, Okinawa, Japan.
- Department of Diagnostic Pathology, Okinawa Chubu Hospital, Okinawa, Japan.
- Department of Diagnostic Pathology, Okinawa Red Cross Hospital, Okinawa, Japan.
- Department of Diagnostic Pathology, Urasoe General Hospital, Okinawa, Japan.
Zitieren
APA
Hirata, Y., Higuchi, K., Tamashiro, K., Koja, K., Yasutomi, Y., Matsuzaki, A., & Yoshimi, N. (2021). Application of the Milan System for Reporting Salivary Gland Cytopathology: A 10-Year Experience in a Single Japanese Institution. Acta Cytologica, 65(2), 123-131. https://doi.org/10.1159/000510990
Vancouver
Hirata Y, Higuchi K, Tamashiro K, Koja K, Yasutomi Y, Matsuzaki A, et al. Application of the Milan System for Reporting Salivary Gland Cytopathology: A 10-Year Experience in a Single Japanese Institution. Acta Cytologica. 2021;65(2):123-131. doi:10.1159/000510990
BibTeX
@article{Hirata2021,
author = {Hirata, Yukiya and Higuchi, Kayoko and Tamashiro, Koichi and Koja, Keisuke and Yasutomi, Yuiko and Matsuzaki, Akiko and Yoshimi, Naoki},
title = {Application of the Milan System for Reporting Salivary Gland Cytopathology: A 10-Year Experience in a Single Japanese Institution},
journal = {Acta Cytologica},
year = {2021},
volume = {65},
number = {2},
pages = {123--131},
doi = {10.1159/000510990}
}
EUVIMED